Compugen Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Compugen Ltd
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
/ 
Frequently asked questions
To buy Compugen Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Compugen Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Compugen Ltd is CGEN:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Compugen Ltd has its primary listing on NASDAQ (Small cap). You can trade Compugen Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Compugen Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Compugen Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Compugen Ltd.